Qiqiang Zeng

1.1k total citations
34 papers, 825 citations indexed

About

Qiqiang Zeng is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qiqiang Zeng has authored 34 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 14 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qiqiang Zeng's work include Pancreatic and Hepatic Oncology Research (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Qiqiang Zeng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Qiqiang Zeng collaborates with scholars based in China, United States and Vietnam. Qiqiang Zeng's co-authors include Qiyu Zhang, Zhengping Yu, Jie You, Ming‐Hua Zheng, Shaoliang Han, Jianling Bai, Yongping Chen, Rong Jin, Hongzhong Zhou and Xiuling Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, World Journal of Gastroenterology and World Journal of Surgery.

In The Last Decade

Qiqiang Zeng

33 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiqiang Zeng China 16 481 193 175 165 146 34 825
Shiu-Feng Huang Taiwan 20 431 0.9× 339 1.8× 292 1.7× 147 0.9× 187 1.3× 42 1.1k
Akiko Yokoi Japan 20 633 1.3× 188 1.0× 567 3.2× 107 0.6× 111 0.8× 80 1.2k
H Kanehiro Japan 11 320 0.7× 362 1.9× 159 0.9× 137 0.8× 80 0.5× 33 856
K Sugimachi Japan 13 352 0.7× 107 0.6× 229 1.3× 81 0.5× 69 0.5× 39 768
Say‐June Kim South Korea 19 687 1.4× 250 1.3× 190 1.1× 321 1.9× 199 1.4× 79 1.2k
Takashi Nishigami Japan 17 425 0.9× 281 1.5× 238 1.4× 60 0.4× 193 1.3× 76 888
Y Kuroda Japan 14 621 1.3× 289 1.5× 145 0.8× 52 0.3× 73 0.5× 63 963
Isaku Yoshioka Japan 13 369 0.8× 273 1.4× 235 1.3× 60 0.4× 68 0.5× 58 661
Masayuki Ishii Japan 18 508 1.1× 385 2.0× 199 1.1× 215 1.3× 99 0.7× 74 879
Matteo Palmeri Italy 17 559 1.2× 582 3.0× 401 2.3× 71 0.4× 44 0.3× 70 1.1k

Countries citing papers authored by Qiqiang Zeng

Since Specialization
Citations

This map shows the geographic impact of Qiqiang Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiqiang Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiqiang Zeng more than expected).

Fields of papers citing papers by Qiqiang Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiqiang Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiqiang Zeng. The network helps show where Qiqiang Zeng may publish in the future.

Co-authorship network of co-authors of Qiqiang Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Qiqiang Zeng. A scholar is included among the top collaborators of Qiqiang Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiqiang Zeng. Qiqiang Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Xiaozai, Yi Wang, Sina Zhang, et al.. (2021). A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma. Aging. 13(2). 2959–2981. 15 indexed citations
2.
3.
Zheng, Kenneth I., Rafael S. Rios, Qiqiang Zeng, & Ming‐Hua Zheng. (2020). COVID-19 Cross-Infection and Pressured Ulceration Among Healthcare Workers: Are We Really Protected by Respirators?. Frontiers in Medicine. 7. 571493–571493. 4 indexed citations
4.
Chen, Gang, Huajun Yu, Yi Wang, et al.. (2018). A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass. Cancer Management and Research. Volume 10. 847–856. 8 indexed citations
5.
Shan, Yunfeng, Mengtao Zhou, Xiangwu Zheng, et al.. (2018). Localized intrahepatic IgG4-related sclerosing cholangitis (IgG4-SC) as an additional type of IgG4-SC: a systematic analysis of 12 cases. Scandinavian Journal of Gastroenterology. 53(3). 312–318. 4 indexed citations
6.
Zheng, Xiangwu, et al.. (2017). Diagnosis and surgical treatment of retroperitoneal paraganglioma: A single-institution experience of 34 cases. Oncology Letters. 14(2). 2268–2280. 25 indexed citations
7.
Xu, Lanman, Yuewen Gong, Benfu Wang, et al.. (2014). Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: Regulation of Treg/Th17 cells. Journal of Gastroenterology and Hepatology. 29(8). 1620–1628. 88 indexed citations
8.
Han, Shaoliang, et al.. (2010). The Surgical Treatment and Outcome for Primary Duodenal Adenocarcinoma. Journal of Gastrointestinal Cancer. 41(4). 243–247. 24 indexed citations
9.
Han, Shaoliang, et al.. (2010). The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma. International Journal of Colorectal Disease. 25(6). 695–702. 33 indexed citations
10.
Han, Shaoliang, et al.. (2010). Analysis of Super-low Anterior Resection for Rectal Cancer from a Single Center. Journal of Gastrointestinal Cancer. 41(3). 159–164. 3 indexed citations
11.
Han, Shaoliang, et al.. (2009). The Surgical Treatment and Outcome for Primary Duodenal Adenocarcinoma. Journal of Gastrointestinal Cancer. 40(1-2). 33–37. 12 indexed citations
12.
Han, Shaoliang, et al.. (2009). FOXP1 Expression Predicts Polymorphic Histology and Poor Prognosis in Gastric Mucosa-Associated Lymphoid Tissue Lymphomas. Digestive Surgery. 26(2). 156–162. 23 indexed citations
13.
Zhang, Weijian, et al.. (2009). Radical resection and outcome for malignant tumors of thepancreatic body and tail. World Journal of Gastroenterology. 15(42). 5346–5346. 11 indexed citations
14.
Zheng, Ming‐Hua, Yongping Chen, Jianling Bai, et al.. (2008). Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Therapy in the Secondary Prophylaxis of Variceal Rebleeding in Cirrhotic Patients. Journal of Clinical Gastroenterology. 42(5). 507–516. 97 indexed citations
15.
Han, Shaoliang, et al.. (2008). The Surgical Treatment and Outcome for Primary Duodenal Adenocarcinoma. Journal of Gastrointestinal Cancer. 39(1-4). 46–50. 33 indexed citations
16.
Lin, Fei, et al.. (2008). Laparoscopically assisted versus open surgery for endometrial cancer—a meta-analysis of randomized controlled trials. International Journal of Gynecological Cancer. 18(6). 1315–1325. 20 indexed citations
17.
Chen, Yunzhi, Qiyu Zhang, Yi Liao, et al.. (2008). A modified canine model of portal hypertension with hypersplenism. Scandinavian Journal of Gastroenterology. 44(4). 478–485. 6 indexed citations
18.
Zeng, Qiqiang, Hongzhong Zhou, Xiangwu Zheng, et al.. (2008). Total Gastrointestinal Tract Necrosis After Ingesting a Considerable Amount of Hydrochloric Acid. Journal of Gastrointestinal Surgery. 13(3). 578–580. 3 indexed citations
19.
Zeng, Qiqiang, Qiyu Zhang, Zhengping Yu, et al.. (2008). Efficacy of Somatostatin and Its Analogues in Prevention of Postoperative Complications After Pancreaticoduodenectomy. Pancreas. 36(1). 18–25. 51 indexed citations
20.
Zheng, Ming‐Hua, et al.. (2007). Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterology. 7(1). 6–6. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026